Press Releases



 
Press Releases
  Date Title View
Jan 27, 2006
REDWOOD CITY, Calif., Jan 27, 2006 /PRNewswire-FirstCall via COMTEX News Network/ -- Genomic Health, Inc. (Nasdaq: GHDX) announced today that it has received a letter from the Food and Drug Administration (FDA) regarding Oncotype DX(TM), the company's genomic-based test for early stage breast cancer patients. The letter invited the company to meet...
PDF
Jan 13, 2006
REDWOOD CITY, Calif., Jan 13, 2006 /PRNewswire-FirstCall via COMTEX News Network/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced that the National Heritage Insurance Company (NHIC), the contractor that administers Medicare programs in California, has established a positive coverage policy for the company's Oncotype DX(TM) breast cancer tes...
PDF
Jan 5, 2006
REDWOOD CITY, Calif., Jan 05, 2006 /PRNewswire-FirstCall via COMTEX News Network/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced that Randy Scott, Ph.D., the Company's Chairman and Chief Executive Officer, will present at the 24th Annual JPMorgan Healthcare Conference on Monday, January 9, 2006 at 3:30 PM Pacific (6:30 PM Eastern) at the W...
PDF
Dec 10, 2005
SAN ANTONIO, Dec 10, 2005 /PRNewswire-FirstCall via COMTEX News Network/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced positive results from a new analysis demonstrating that the same Oncotype DX(TM) Recurrence Score(TM) that quantifies distant recurrence for a large portion of early-stage breast cancer patients is also a significant pred...
PDF
Dec 9, 2005
SAN ANTONIO, Dec 09, 2005 /PRNewswire-FirstCall via COMTEX News Network/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced results of a community-based, investigator-sponsored study that demonstrated its Oncotype DX(TM) 21-gene panel breast cancer test, which quantifies the likelihood of recurrence and predicts chemotherapy benefit for a larg...
PDF
Dec 5, 2005
REDWOOD CITY, Calif., Dec 05, 2005 /PRNewswire-FirstCall via COMTEX News Network/ -- Genomic Health, Inc. (Nasdaq: GHDX) announced today that results from three new analyses of the company's Oncotype DX(TM) breast cancer test, which quantifies the likelihood of recurrence and predicts chemotherapy benefit for a large portion of early stage breast ...
PDF
Nov 3, 2005
REDWOOD CITY, Calif., Nov 03, 2005 /PRNewswire-FirstCall via COMTEX News Network/ -- Genomic Health, Inc. (Nasdaq: GHDX) today reported financial results for the third quarter and nine months ended September 30, 2005. Total revenue was $1,592,000 in the third quarter of 2005, compared to $167,000 in the third quarter of 2004, driven by growth of O...
PDF
Oct 28, 2005
REDWOOD CITY, Calif., Oct 28, 2005 /PRNewswire-FirstCall via COMTEX News Network/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced that the company will host a conference call and webcast on Thursday, November 3 at 4:30 p.m. Eastern Time (1:30 p.m. Pacific) to discuss its third quarter 2005 financial results. The call and webcast will foll...
PDF
Sep 28, 2005
REDWOOD CITY, Calif., Sept. 28, 2005 /PRNewswire-FirstCall/ -- Genomic Health, Inc. today announced the pricing of its initial public offering of 5,016,722 shares of its Common Stock at $12.00 per share. J.P. Morgan Securities Inc. and Lehman Brothers Inc. acted as joint book-running managers for this offering, and Piper Jaffray & Co., Thomas Weise...
PDF
May 17, 2005
ORLANDO - May 17, 2005 - Genomic Health, Inc. announced that results from three independent studies evaluating the Oncotype DX breast cancer assay were presented at the 41st annual meeting of the American Society of Clinical Oncology (ASCO). These studies examined the assay's ability to quantify likelihood of recurrence, predict response to c...
PDF
FirstPrevious
...
40
NextLast